Connor Clark & Lunn Investment Management Ltd. increased its position in shares of Pulmonx Co. (NASDAQ:LUNG – Free Report) by ...

Patients with LORA and CLD at baseline had lower rates of treatment response and a higher risk for SAEs over 5 years, compared against those without CLD.

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8568 ...

LYON, France, March 3, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Glen French to its Board of ...

Endobronchial valves are medical devices used primarily to treat severe emphysema, a form of chronic obstructive ... This alarming statistic underscores the need for effective treatment options, ...

Rhumbline Advisers raised its holdings in shares of Pulmonx Co. (NASDAQ:LUNG – Free Report) by 4.9% during the fourth quarter ...

Here is a look at the NEET UG 2025 syllabus and answers to frequently asked questions regarding the Biology subject.

Targeting final FDA approval of YUTREPIA™ after expiration of regulatory exclusivity on May 23, 2025Advancing pipeline of inhaled treprostinil ...

Sexual reproduction in flowering plants: Flower structure; Development of male and female gametophytes; Pollination-types, agencies and examples; Outbreeding devices; Pollen-Pistil interaction ...

“However, it could be cancer from a different site, a lung infection, or another disease that makes the lung non-functional, such as a serious emphysema ... It's a common treatment if ...

Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Infertility Treatment Devices Patent Landscape Report" report has been added to ResearchAndMarkets.com's offering. A comprehensive analysis of the ...